Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK07 Formoterol and budesonide
D09595 Budesonide and formoterol fumarate dihydrate <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilator Combinations
Budesonide/ Formoterol Fumarate Dihydrate
D09595 Budesonide and formoterol fumarate dihydrate
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D09595 Budesonide and formoterol fumarate dihydrate
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09595 Budesonide and formoterol fumarate dihydrate
DG02924 UGT substrate
D09595 Budesonide and formoterol fumarate dihydrate
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09595
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09595